Stimuli-responsive multifunctional metal-organic framework- based injectable hydrogel for the treatment of breast cancer

被引:0
作者
Ukani, Hiral [1 ]
Singh, Priya [2 ]
Banerjee, Monidipa [2 ]
Parsana, Nildhara [1 ]
Mehra, Sanjay [3 ,4 ]
Kumar, Arvind [3 ,4 ]
Kadam, Yogesh [2 ]
Malek, Naved [1 ]
机构
[1] Ionic Liquids Research Laboratory, Department of Chemistry, Sardar Vallabhbhai National Institute of Technology, Surat
[2] Department of Chemistry, School of Science and Technology, Vanita Vishram Women's University, Surat
[3] Academy of Scientific and Innovative Research (AcSIR), Ghaziabad
[4] Salt and Marine Chemicals Division, CSIR-Central Salt and Marine Chemicals Research Institute, Council of Scientific and Industrial Research, G. B. Marg, Gujarat, Bhavnagar
关键词
5-Fluoro uracil; Drug delivery; Hydrogel; Metal organic framework; MIL-100(Fe);
D O I
10.1016/j.molliq.2024.126022
中图分类号
学科分类号
摘要
In the pursuit of improved cancer treatment, the drug delivery vehicle should encapsulate and release the drug in the consistent and controlled manner at the targeted site and helps in optimizing the therapeutic results. To design similar system, in the present investigation we introduce an innovative approach of developing the hydrogels through combining MIL-100(Fe), a biocompatible metal–organic frameworks (MOFs) with the biocompatible polymers, i.e. Xanthan gum and Carbomer 940. The resulted hydrogels showcase remarkable attributes, including swelling ability, self-healing property, and injectability along with the excellent mechanical stability. Morphological analysis confirms 3-D porous structures of hydrogels that facilitates encapsulation of drug molecules within its networks. These MOF-based hydrogel stands out for its exceptional drug loading efficiency for the anticancer drug, 5-Fluorouracil (5-FU) and its ability to respond to physiological stimuli, ensuring precise and controlled drug release. These hydrogels were tested and found to be biocompatible to blood in hemolysis test and to normal human cells (HaCat) in MTT assay. Additionally, they showed great potential against cancerous cells (MCF-7), proving their effectiveness as a way to deliver drug for treating breast cancer. © 2024 Elsevier B.V.
引用
收藏
相关论文
共 70 条
  • [1] Feng Y., Spezia M., Huang S., Yuan C., Zeng Z., Zhang L., Ji X., Liu W., Huang B., Luo W., Liu B., Lei Y., Du S., Vuppalapati A., Luu H.H., Haydon R.C., He T.-C., Ren G., Breast cancer development and progression: risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesis, Genes Dis., 5, pp. 77-106, (2018)
  • [2] Arnold M., Morgan E., Rumgay H., Mafra A., Singh D., Laversanne M., Vignat J., Gralow J.R., Cardoso F., Siesling S., Soerjomataram I., Current and future burden of breast cancer: global statistics for 2020 and 2040, Breast, 66, pp. 15-23, (2022)
  • [3] Cheng Z., Li M., Dey R., Chen Y., Nanomaterials for cancer therapy: current progress and perspectives, J. Hematol. Oncol., 14, (2021)
  • [4] Tang X., Loc W.S., Dong C., Matters G.L., Butler P.J., Kester M., Meyers C., Jiang Y., Adair J.H., The use of nanoparticulates to treat breast cancer, Nanomedicine, 12, pp. 2367-2388, (2017)
  • [5] Ukani H., Parmar B., Parsana N., Kumar S., Aswal V.K., El Seoud O., Malek N., Metal organic framework coated vesicular nano-aggregates: an intelligent ‘vehicle’ for sustained and leakage proof release of doxorubicin, New J. Chem., 48, pp. 10538-10551, (2024)
  • [6] Shah A., Jain M., Lad V.N., Ray D., Aswal V.K., Malek N.I., Selective accumulation of dyes and curcumin in a macroscopic complex coacervates composed of morpholinium based ester functionalized ionic liquid and sodium salicylate, J. Mol. Liq., 317, (2020)
  • [7] Ukani H., Pratyush S., Kumar V.K., Aswal A.A., Al-Ghamdi N.I.M., Cholesterol mediated stable vesicles: a nano drug delivery vehicle for anti-cancer drugs curcumin and 5-fluorourecil, ChemistrySelect, 7, (2022)
  • [8] Pansuriya R., Patel T., Mehra S., Kumar A., El Seoud O.A., Kumar S., Aswal V.K., Kailasa S.K., Malek N.I., A dual responsive ionic liquid-based polymeric hydrogel: a promising drug delivery vehicle for the treatment of breast cancer, New J. Chem., 47, pp. 14261-14272, (2023)
  • [9] Fan D., Tian Y., Liu Z., Injectable hydrogels for localized cancer therapy, Front. Chem., 7, (2019)
  • [10] Zeng Y., Zhang C., Du D., Li Y., Sun L., Han Y., He X., Dai J., Shi L., Metal-organic framework-based hydrogel with structurally dynamic properties as a stimuli-responsive localized drug delivery system for cancer therapy, Acta Biomater., 145, pp. 43-51, (2022)